Lv1
18 积分 2025-09-30 加入
Minimal residual disease as a target for liquid biopsy in patients with solid tumours
14小时前
待确认
Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma
15小时前
已完结
Robotic vs Laparoscopic Surgery for Middle and Low Rectal Cancer
2个月前
已完结
Research status of rare metastases of pancreatic cancer and the exploration of therapies
3个月前
已完结
An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence
4个月前
已完结
An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence
4个月前
已关闭
Circulating tumour DNA: a challenging innovation to develop “precision onco-surgery” in pancreatic adenocarcinoma
4个月前
已完结
Circulating tumor DNA (ctDNA) to evaluate minimal residual disease (MRD), treatment response, and posttreatment prognosis in pancreatic adenocarcinoma
4个月前
已完结
Prognostic utility of preoperative and postoperative KRAS-mutated circulating tumor DNA (ctDNA) in resected pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
4个月前
已完结
Developments in pancreatic cancer emerging therapies, diagnostic methods, and epidemiology
4个月前
已完结
皖公网安备34019202002308
